IQVIA - Latest News and Information
Technology Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
IQV
IQVIA is a global leader in life sciences data, technology, and human science, providing advanced analytics and real-world evidence to accelerate clinical development, regulatory processes, and market access. The company supports life sciences organizations across multiple regions with solutions spanning research and development, commercialization, safety, and regulatory compliance. Through its global reach and data-driven technologies, IQVIA aims to improve patient outcomes and speed treatments to market worldwide.
IQVIA (IQV) Launches IQVIA.ai Unified Agentic AI Platform with Nvidia
Hacker Group LAPSUS$ Claims Alleged AstraZeneca Data Breach
KERV.ai Receives Series B Funding From Coral Tree Partners, Fueling Next Phase of Growth in AI-Powered Contextual Commerce Media Solutions
Pharmaceutical Logistics in Demand as War Rattles Supply Chains
3 Trends Shaping the GLP-1 Landscape
From Free Rider to Innovator: How China Became a Global Pharmaceutical Powerhouse
IQVIA (IQV) Launches IQVIA.ai Unified Agentic AI Platform with Nvidia
AVOXI Proactive Service SaaS Uses AI to Detect Voice Channel Issues Before Clients 97% of the Time
SpotSee-Controlant Collaboration Addresses Shipment Monitoring Gaps in Temperature-Sensitive Supply Chains
Cipla Secures FDA Approval for Generic Nintedanib Capsules, Expanding U.S. IPF Portfolio
Weekly TechBio News 🌟🎄
FDA Requires Warning About Rare but Severe Itching After Stopping Long-Term Use of Oral Allergy Medicines Cetirizine or Levocetirizine (Zyrtec, Xyzal, and Other Trade Names)
The Multi-Purpose Paradigm: Scaling AI ROI and De-Risking the Life Sciences Value Chain
Omada Receives Dual Recognition as Leader and Emerging Innovator in QKS Group’s SPARK Matrix™ for Identity Governance & Administration (IGA)
Otsuka Preps for July Decision on Centanafadine for ADHD
Decision Criteria for Technology Commercialization of Medical Devices in 2026
Wegovy Pill Shows Strong Early Uptake, as Rival Looms
IQVIA Signs Agreement to Acquire Drug Discovery Assets From Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities
Roche Claims Midstage Win for Obesity Injectable
When Regulation and AI Converge: SymphonyAI Joins the FCA Supercharged Sandbox to Pioneer Responsible Fintech Innovation
FDA Adds Warning About Rare Occurrence of Serious Liver Injury with Use of Veozah (Fezolinetant) for Hot Flashes Due to Menopause
Pharvaris NV (PHVS) Q4 2025 Earnings Call Transcript
Nvidia Launches Enterprise AI Agent Platform with Adobe, Salesforce, SAP Among 17 Adopters at GTC 2026
No recent deals for this company.
